TCT 364: Complementary use of IVUS With Rotational Atherectomy in Calcified Coronary Lesions - Real World Data From the ROVUS Asia Registry
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Boston Scientific Corporation; Philips